18. Palladium(II)-Catalyzed Direct Intermolecular Alkenylation of Chromones
Kim, D.; Hong, S.
Org. Lett. 2011, 13, 4466-4469.
17. Identification of Novel BRAF Kinase Inhibitors with Structure-Based Virtual Screening
Park, H.; Choi, H.; Hong, S.; Hong, S.
Bioorg. Med. Chem. Lett. 2011, 21, 5753.
16. Synergistic Effect of Graphene Oxide/MWCNT Films in Laser Desorption/Ionization Mass Spectrometry of Small Molecules and Tissue Imaging
Kim, Y.-K.; Na, H.-K.; Kwack, S.-J.; Ryoo, S.-R.; Lee, Y.; Hong, S.; Hong, S.; Jeong, Y.; Min, D.-H.
ACS. Nano. 2011, 5, 4550-4561.
15. Overcoming Metastatic Melanoma with BRAF Inhibitors
Hong, S.; Hong, S.
Arch. Pharm. Res. 2011, 34, 699-701.
14. Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells
Choi, M; Jung, K. H.; Kim, D.; Lee, H.; Zheng, H.;Park, B. H.; Hong, S.-W., Kim, M.; Hong, S.*; Hong, S.-S.*
Cancer Lett. 2011, 306, 190.
13. Fluorescent Phosphoinositide 3-kinase Inhibitors Suitable for Monitoring of Intracellular Distribution
Kim, D.; Lee, H.; Jun, H.; Hong, S.-S.; Hong, S.
Bioorg. Med. Chem. 2011, 19, 2508.
12. Design and Synthesis of Imidazopyridine Analogues as Inhibitors of Phosphoinositide 3-kinase Signaling and Angiogenesis
Kim, O.; Jeong, Y.; Lee, H.; Hong, S.-S.; Hong, S.
J. Med. Chem. 2011, 54, 2455.
11. Structure-Based Virtual Screening Approach to the Discovery of Phosphoinositide 3-Kinase Alpha inhibitors
Park, H.; Choi, H.; Hong, S.; Kim, D.; Oh, D.-S.; Hong, S.
Bioorg. Med. Chem. Lett. 2011, 21, 2021.
10. Discovery of New Azaindole-based PI3Ka Inhibitors: Apoptotic and Antiangiogenic Effect on Cancer Cells
Hong, S.; Lee, S.; Kim, B.; Lee, H; Hong, S.-S.; Hong, S.
Bioorg. Med. Chem. Lett. 2010, 20, 7212-7215.
9. Development of New Fluorescent Xanthines as Kinase Inhibitors
Kim, D.; Jun, H.; Lee, H.; Hong, S.-S.; Hong, S.
Org. Lett. 2010, 12, 1212-1215.
